News

Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
TMCnet3d
WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year
WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized by CDP, the world's foremost ...
The Diplomat5d
As US Decouples, China Strengthens Biotech Ties With Japan
From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.
GEN - Genetic Engineering and Biotechnology News6d
WuXi Biologics Reports Completion of First Commercial PPQ Campaign at 15,000 L Production Line
Single-use technology manufacturing can attain cost-of-goods that are comparable to stainless-steel systems, noted WuXi.
Small Molecule Innovator API CDMO Market To Hit $47.14 Billion By 2030 At 6.38% CAGR, Driven By Outsourcing Trends And Drug Innovation
CDMOs Expand Capabilities Amid Surge in Clinical Trials and Demand for Orphan Drugs and Novel TherapiesDublin, April 18, 2025 (GLOBE NEWSWI ...
Salamanca Press6d
WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site
The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,000L single-use bioreactors ...